Valeurs

Valeurs

Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices.

Show advanced options

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Nom	Code	Analysis date	Cours de clôture	+/- %
Mastermyne Group Limited	024	13. mar 2025	0.07	+3.52
Matador Resources Company	7MR	13. mar 2025	44.20	+2.79
Matas	1MTA	13. mar 2025	17.42	+0.11
Match Group, Inc.	4MGN	13. mar 2025	27.66	-1.32
Materialise NV - American Depositary Shares	06MA	13. mar 2025	4.48	-0.44
Materion Corporation	BEM	13. mar 2025	75.50	-1.95
Maternus-Kliniken AG	MAK	13. mar 2025	1.39	-4.14
Matrix Composities & engineering Ltd	8ME	13. mar 2025	0.10	-7.14
Matrix Service Company	MX2	13. mar 2025	11.30	+1.80
Matsa Resources Limited	KB2	13. mar 2025	0.03	0.00
Matson, Inc.	68M	13. mar 2025	121.00	+0.83
Matsui Securities Co.	MTW	13. mar 2025	4.80	0.00
Mattel, Inc.	MTT	13. mar 2025	18.75	-0.90
Matthews International Corporation - Class A	MW1A	13. mar 2025	20.54	-0.29
MATTR CORP.	Y6R	13. mar 2025	5.80	-0.85
Mauna Kea Technologies SA	1MK	13. mar 2025	0.15	0.00
Maven Wireless Sweden AB	96W	13. mar 2025	0.77	+1.85
Mavshack	2MV	13. mar 2025	0.00	0.00
MAX Automation SE	MXHN	13. mar 2025	6.02	+0.67
Max Resource Corp.	M1D2	13. mar 2025	0.03	+6.49
MAXCYTE INC COM	MYE0	13. mar 2025	2.80	+2.94
Maxell Holdings Ltd.	0H2	13. mar 2025	11.60	+1.75
Maxeon Solar Technologies	5QJ1	13. mar 2025	2.78	-4.79
MAXIM POWER CORP. NEW	MP9	13. mar 2025	2.92	+2.82
Maximus Resources Ltd	M5F	13. mar 2025	0.03	+1.61
Maximus, Inc.	MMY	13. mar 2025	60.50	-2.42
MaxLinear, Inc.	JMX	13. mar 2025	11.39	-1.68
Mayfair Gold Corp	9M5	13. mar 2025	1.11	+0.91
Mayne Pharma Group Limited	HG6	13. mar 2025	4.14	-0.48
Mayora Indah Tbk	D7V	13. mar 2025	0.11	-0.89

Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.